TherapeuticsMD (TXMD) Total Liabilities (2010 - 2026)

TherapeuticsMD's Total Liabilities history runs 17 years deep, the most recent figure standing at $10.6 million for Q1 2026.

• Quarterly Total Liabilities fell 7.72% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (down 7.72% YoY) and the FY2025 annual result came in at $10.8 million, down 5.87% from the prior year.
• Total Liabilities was $10.6 million for Q1 2026 at TherapeuticsMD, down from $10.8 million in the prior quarter.
• Across five years, Total Liabilities topped out at $274.0 million in Q1 2022 and bottomed at $10.6 million in Q1 2026.
• A 5-year average of $51.5 million and a median of $13.4 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities increased 10.12% — and 2023, when it tumbled 89.93%.
• TherapeuticsMD's Total Liabilities stood at $55.3 million in 2022, then sank by 74.65% to $14.0 million in 2023, then slipped by 18.33% to $11.5 million in 2024, then decreased by 5.87% to $10.8 million in 2025, then retreated by 1.6% to $10.6 million in 2026.
• Business Quant data shows TXMD's Total Liabilities at $10.6 million in Q1 2026, $10.8 million in Q4 2025, and $11.2 million in Q3 2025.